The expected moves are part of the administration’s broader strategy to protect the U.S. against supply shortages seen during the COVID pandemic that left hospitals scrambling to find critical equipment, the sources said.

Imports of syringes from China peaked at $348 million in 2021, but have declined since to about $167 million last year, according to U.S. Census Bureau data.

Read the article.